We are live on ! Find out more
MIST icon

Milestone Pharmaceuticals
MIST

39 hedge funds and large institutions have $60.7M invested in Milestone Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 14 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more call options, than puts

Call options by funds: $601K | Put options by funds: $290K

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

3% more capital invested

Capital invested by funds: $59M → $60.7M (+$1.71M)

3.38% less ownership

Funds ownership: 62.01% → 58.63% (-3.4%)

19% less funds holding

Funds holding: 48 → 39 (-9)

36% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 14

82% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 11

Holders
39
Holders Change
-9
Holders Change %
-18.75%
% of All Funds
0.62%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
2
Increased
9
Reduced
14
Closed
11
Calls
$601K
Puts
$290K
Net Calls
+$311K
Net Calls Change
+$328K

Top Buyers

1
AFA
Alta Fundamental Advisers
New York
+$865K
2
BlackRock
BlackRock
New York
+$403K
3
AAA
Affinity Asset Advisors
New York
+$109K
4
Osaic Holdings
Osaic Holdings
Arizona
+$19.2K
5
Goldman Sachs
Goldman Sachs
New York
+$10.7K

Top Sellers

1
BC
Boxer Capital
California
-$1.21M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$663K
3
Citadel Advisors
Citadel Advisors
Florida
-$539K
4
Barclays
Barclays
United Kingdom
-$483K
5
Morgan Stanley
Morgan Stanley
New York
-$325K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
26
State Street
Massachusetts
$67K – – –
Envestnet Asset Management
27
Envestnet Asset Management
Illinois
$58.8K +$2.85K +918 +5%
Geode Capital Management
28
Geode Capital Management
Massachusetts
$54.5K – – –
Osaic Holdings
29
Osaic Holdings
Arizona
$53.6K +$19.2K +6,180 +56%
PAM
30
PVG Asset Management
Colorado
$47.8K – – –
BWG
31
Beta Wealth Group
California
$43.8K – – –
Creative Planning
32
Creative Planning
Kansas
$40.5K – – –
FDCDDQ
33
Federation des caisses Desjardins du Quebec
Quebec, Canada
$32.5K – – –
National Bank of Canada
34
National Bank of Canada
Quebec, Canada
$11.3K – – –
BNP Paribas Financial Markets
35
BNP Paribas Financial Markets
France
$6.51K -$27.1K -8,710 -81%
Bank of America
36
Bank of America
North Carolina
$6.06K -$36.4K -11,721 -86%
UBS Group
37
UBS Group
Switzerland
$5.25K -$5.11K -1,644 -49%
Qube Research & Technologies (QRT)
38
Qube Research & Technologies (QRT)
United Kingdom
$601 +$603 +194 New
OLVIG
39
Oliver Lagore Vanvalin Investment Group
Michigan
$310 +$311 +100 New
Point72 Asset Management
40
Point72 Asset Management
Connecticut
– -$663K -232,659 Closed
Renaissance Technologies
41
Renaissance Technologies
New York
– -$310K -108,766 Closed
Two Sigma Investments
42
Two Sigma Investments
New York
– -$149K -52,186 Closed
HighTower Advisors
43
HighTower Advisors
Illinois
– -$88K -31,000 Closed
Two Sigma Advisers
44
Two Sigma Advisers
New York
– -$73.2K -25,700 Closed
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
– -$66.3K -23,261 Closed
CSS
46
Cubist Systematic Strategies
Connecticut
– -$36.9K -12,957 Closed
VF
47
Virtu Financial
New York
– -$33K -11,743 Closed
Simplex Trading
48
Simplex Trading
Illinois
– -$11.2K -3,588 Closed
TRCT
49
Tower Research Capital (TRC)
New York
– -$490 -172 Closed
IGWM
50
ICA Group Wealth Management
Colorado
– -$285 -100 Closed
1
2

MIST Hedge Fund Activity: Q3 2023 in Review

39 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Milestone Pharmaceuticals (MIST) for Q3 2023, worth a combined $60.7M — up 2.9% from $59M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of MIST and 2 opened new positions — a net loss of 9 holders — while 14 trimmed existing stakes and 9 added.

The largest buyer was Alta Fundamental Advisers, adding an estimated $865K. The largest seller was Boxer Capital, cutting an estimated $1.21M.

  • 39 institutional investors held Milestone Pharmaceuticals (MIST) as of Q3 2023, down from 48 in Q2 2023.
  • Funds reported $60.7M of Milestone Pharmaceuticals stock for Q3 2023, up 2.9% quarter-over-quarter.
  • 2 funds opened new Milestone Pharmaceuticals positions in Q3 2023 and 11 closed out, a net change of -9 holders.
  • The largest Milestone Pharmaceuticals buyer in Q3 2023 was Alta Fundamental Advisers, an estimated $865K added.
  • The largest Milestone Pharmaceuticals seller in Q3 2023 was Boxer Capital, an estimated $1.21M sold.

Based on aggregated 13F filings for Q3 2023.